Pfizer and Allergan to merge in $160 billion inversion

November 23, 2015 2:09 PM

51 0

Pfizer and Allergan to merge in $160 billion inversion

Pfizer and Allergan on Monday morning announced they would merge in a massive, $160 billion deal that will create the world's largest drugmaker, producing treatments as varied as Lipitor and Botox.

The deal is structured as a reverse-merger, with smaller Dublin-based Allergan buying U.S.-based Pfizer, and it is likely to renew concern in the United States over "inversions," where U.S. companies are bought by or merge with foreign firms in order to reduce U.S. corporate tax burdens. Just days a...

Also read: Consolidated Communications to buy FairPoint in $1.5 billion deal

Read more

To category page

Loading...